Latest News
-
Tuesday - March 20, 2018
Bayer and Ginkgo Bioworks unveil joint venture, Joyn Bio, and establish operations in Boston and West Sacramento
Joyn Bio’s initial efforts focus on nitrogen fixation to enhance sustainability in agriculture / Researchers will broadly explore application of beneficial microbes to plants for next generation solutions to agriculture’s biggest challenges / Dr. Mike Miille appointed as CEO » more
-
Monday - March 19, 2018
Scientific leaders unite to tackle global parasitic threat in dogs and cats
ESDA 2018 Congress will see over 150 thought leaders and scientists gather in Belgrade to discuss developments of Dirofilaria and Angiostrongylus vasorum in companion animals / Call for registration: veterinary practitioners, academics and scientists are welcome to attend the Congress. Registration opens from June 15: https://www.esda.vet/esda-belgrade-2018/ » more
-
Tuesday - March 13, 2018
Bayer moves its transparency initiative into the next phase
First full, in-depth safety studies are accessible via the Bayer platform / Bayer reconfirms its commitment to transparency by supporting the European Commission’s call for greater transparency around crop protection safety studies » more
-
Wednesday - March 7, 2018
Bayer in exclusive talks with BASF on the sale of vegetable seeds business » more
-
Friday - March 2, 2018
Modern labor and water efficient methods:
Bayer partners with IRRI to advance technologies for direct-seeded rice in Asia
Bayer joins Direct Seeded Rice Consortium led by IRRI / Public-private partnership model aims to make direct seeded rice accessible to rice farmers, thereby increasing the economic and ecological sustainability of rice farming in Asia » more
-
Wednesday - February 28, 2018
Financial News Conference
Full Year 2017 Results » more
-
Wednesday - February 28, 2018
Fiscal 2017:
Bayer: business at prior-year level – on track with strategy
Group sales increased by 1.5 percent (Fx & portfolio adj.) to 35.015 billion euros / Another record year for Pharmaceuticals / Weak business development at Consumer Health / Crop Science business down against prior year due to situation in Brazil – measures taking effect / EBITDA before special items level year on year at 9.288 billion euros / Net income raised by 61.9 percent to 7.336 billion euros / Core earnings per share increased by 1.0 percent to 6.74 euros / Covestro deconsolidated – additional cash inflows of 4.7 billion euros / Monsanto acquisition expected to close in second quarter of 2018 / Group outlook for 2018: increase in sales (Fx & portfolio adj.), EBITDA before special items and core earnings per share at prior-year level due to currency effects » more
-
Wednesday - February 28, 2018
EFSA’s conclusions do not justify further neonicotinoid use restrictions
Risk assessments are based on the unapproved Bee Guidance Document, which disregards the interests of EU member states / Conclusions are at odds with other comprehensive scientific evaluations » more
-
Tuesday - February 27, 2018
Bayer proposes increased dividend for 2017 of 2.80 euros per share
Payment per share rises 3.7 percent » more
-
Wednesday - February 21, 2018
Not intended for U.S. and UK Media
Bayer announces publication of larotrectinib data in The New England Journal of Medicine
Larotrectinib demonstrated marked and durable anti-tumor activity in TRK fusion cancers regardless of patient age or tumor type / 75 percent overall response rate (ORR) in TRK fusion adult and pediatric cancers by central assessment; 80 percent ORR by investigator assessment / 86 percent of responding patients remained on larotrectinib or underwent surgery with curative intent » more
-
Friday - February 16, 2018
New round of sponsorships in Role Model Program:
Ten years of Bayer support for employees’ volunteering work
Bayer Cares Foundation awards over EUR 402,000 to 113 projects worldwide in 2017 / Highest sum ever paid out in one year / Winning projects provide answers to education, health and food security challenges / 745 projects supported and over EUR 2.6 million spent since 2007 » more
-
Thursday - February 15, 2018
Helping growers worldwide control major diseases:
Bayer and Mitsui Chemicals Agro sign licence agreement for novel fungicide » more
-
Tuesday - February 13, 2018
Not intended for U.S. and UK Media
Bayer receives first approval for Eylea® in China
Eylea is the first anti-VEGF drug approved in China for the treatment of visual impairment due to diabetic macular edema in patients with DME » more
-
Tuesday - February 13, 2018
Bayer People Care for Society – the international talent program:
Three-month social sabbaticals helping to develop solutions to healthcare and food security challenges worldwide
Bayer talents dedicate professional skills to tackling major health and food challenges in social impact assignments worldwide / Bayer Cares Foundation coordinates assignment locations / Seven employees supported with total donations of EUR 50,000 in current round » more
-
Monday - February 12, 2018
Not intended for U.S. and UK Media
New data for aflibercept show prolonged injection intervals
Data from ALTAIR study demonstrate injection appointments at an interval of 12 weeks or more / New data submitted to EMA to update the current product information » more
-
Wednesday - February 7, 2018
Not intended for U.S. and UK Media: 2018 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium:
Bayer to showcase latest prostate cancer research at ASCO GU 2018 Cancer Symposium
New data on the long-term efficacy and safety of Xofigo® (radium-223 dichloride) / Update on ongoing studies with darolutamide, a novel investigational oral androgen receptor (AR) antagonist, including the ARASENS pivotal trial in men with metastatic hormone-sensitive prostate cancer (mHSPC) » more
-
Wednesday - February 7, 2018
Agreements will be signed at Fruit Logistica:
Bayer and NGOs collaborate to support smallholder farmers
Farmers will benefit from expertise, technologies, and better access to markets / Solidaridad supports smallholder farmers to produce food sustainably / Triptolemos Foundation commissions UNESCO Chair to innovate global food system » more
-
Tuesday - January 23, 2018
Higher crop yields via mobile phone:
Bayer supports innovative myAgro start-up with funding of more than USD 600,000 to assist smallholder farmers in West Africa
Small amounts of money are saved by farmers via mobile phones in the form of myAgro scratch cards and exchanged for high-quality seed and fertilizer / Bayer’s donation will help expand this social innovation to other regions of Africa and and support an initiative to combat infections » more
-
Monday - April 24, 2017
World Malaria Day 2017:
Bayer partners with Goodbye Malaria to help “End Malaria for Good” » more
-
Monday - December 12, 2016
Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing
BlueRock Therapeutics is focused on breakthrough treatments based on latest stem cell technology in combination with superior cell differentiation protocols / BlueRock Therapeutics’ vision is to cure diseases with significant cell loss and diminished self-repair potential with an initial focus on cardiovascular, neurological and other conditions » more
Copyright @ Bayer AG
Search
Publications
Newsletter
Events
Thursday, February 27, 2020
Financial News Conference on the Full Year 2019 Results
Additional Press Events
Investor Relations Events
BayKomm Events
Download Center - Selection
Bayer TV